BROKERS CHOICE, Fund Houses Recommendations : INFOEDGE, GRASIM, ABB, CONCOR, HINDALCO, INOXWIND, SIEMENS
AHMEDADAB, 12 AUGUST:
અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ દ્વારા પસંદગીના સ્ટોક્સમાં ખરીદી/ વેચાણ/ હોલ્ડ કરવા માટે સલાહ આપવામાં આવી છે તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.
Nomura on Info Edge: Maintain Buy on Company, target price at Rs 8280/Sh (Positive)
Jefferies on JB Chemicals: Maintain Buy on Company, raise target price at Rs 2230/Sh (Positive)
Citi on Grasim: Maintain Buy on Company, raise target price at Rs 3250/Sh (Positive)
Citi on Jubilant Food: Maintain Buy on Company, raise target price at Rs 715/Sh (Positive)
Jefferies on ABB: Maintain Buy on Company, raise target price at Rs 9230/Sh (Positive)
Investec on Auro Pharma: Maintain Buy on Company, target price at Rs 1400/Sh (Positive)
Jefferies on Concor: Maintain Buy on Company, target price at Rs 1195/Sh (Positive)
Nomura on Eureka: Maintain Buy on Company, target price at Rs 573/Sh (Positive)
Jefferies on Hindalco: Maintain Buy on Company, target price at Rs 825/Sh (Positive)
Nuvama on Inox Wind: Maintain Buy on Company, target price at Rs 201/Sh (Positive)
Kotak on Siemens: Maintain Sell on Company, cut target price at Rs 4600/Sh (Neutral)
Jefferies on Honasa: Maintain Buy on Company, cut target price at Rs 545/Sh (Neutral)
GS on Info Edge: Maintain Sell on Company, raise target price at Rs 5700/Sh (Neutral)
BofA on Zydus Life: Maintain Neutral on Company, raise target price at Rs 1310/Sh (Neutral)
Jefferies on Zydus Life: Maintain Hold on Company, target price at Rs 1210/Sh (Neutral)
MS on Trent: Maintain Equal weight on Company, target price at Rs 4812/Sh (Neutral)
CLSA on Jubilant Food: Maintain Underperform on Company, cut target price at Rs 445/Sh (Neutral)
Nomura on Balkrishna: Maintain Neutral on Company, target price at Rs 3115/Sh (Neutral)
Nuvama on CESC: Maintain Reduce on Company, target price at Rs 154/Sh (Neutral)
Nomura on Alkem Labs: Maintain Neutral on Company, target price at Rs 5605/Sh (Neutral)
Jefferies on Alkem Labs: Maintain Underperform on Company, target price at Rs 5080/Sh (Neutral)
Citi on Balkrishna: Maintain Sell on Company, target price at Rs 2150/Sh (Negative)
HSBC on Alembic Pharma: Downgrade to Reduce on Company, target price at Rs 1080/Sh (Negative)
HSBC on Biocon: Downgrade to Reduce on Company, target price at Rs 300/Sh (Negative)
CLSA on Oil India: Downgrade to Underperform on Company, valuations are expensive (Negative)
JPMorgan on Global Health: Downgrade to Underweight on Company, cut target price at Rs 980/Sh (Negative)
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ #ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)
